Irene Malaty is a Neurology physician affiliated with University of Florida. OpenAlex indexes 220 publications with 9,397 citations (h-index 44); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1600 SW Archer Rd
Gainesville, FL 326103003
Telephone
352-273-5550Registry record last updated 21 Nov 2011.
Clinical trials
- Zinc as an Adjunctive Therapy for Cervical Dystonia
Sponsor: University of Florida
- Sensory Processing in Tourette Syndrome
Sponsor: University of Florida
- Ampicillin for DYT-1 Dystonia Motor Symptoms
Sponsor: University of Florida
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year202512 payments$20,901openpaymentsdata.cms.gov ↗
- ABBVIE INC.Program year20247 payments
- CSL BehringProgram year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Musculoskeletal
99.5%Neuromuscular Blocker99.5%Onabotulinumtoxina100%Part B, office-administered≥113 patientsNervous system
0.5%Aromatic Amino Acid Decarboxylation Inhibitor0.2%Carbidopa-Levodopa63%Carbidopa-Levodopa Er22%Rytary9%Carbidopa6%Part D<11 patientsAtypical Antipsychotic0.1%Clozapine100%Part D<11 patients+ 8 more classes in this area
Cardiovascular
0%Central alpha-2 Adrenergic Agonist0%Clonidine Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- TikTok Tourette’s: Are We Witnessing a Rise in Functional Tic-Like Behavior Driven by Adolescent Social Media Use?
Psychology Research and Behavior Management
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Steven Dekosky, MD
University of Florida
Brian Hoh, MD
University of Florida
Frederic Kaye, MD
University of Florida
Kelly Foote, MD
University of Florida
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”